FIELD: pharmaceutical industry.
SUBSTANCE: claimed composition contains fexofenadine, polyvinylpyrrolidone, milk sugar, microcrystalline cellulose, crosscarmelose sodium and stearic acid salt. Composition may be made in form of tablet with soluble in stomach coating.
EFFECT: composition with fast releasing of active ingredient without side effect on gastrointestinal tract.
10 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR ALLERGIC DISEASES | 2010 |
|
RU2453315C2 |
| PHARMACEUTICAL COMPOSITIONS FOR PROLONGED RELEASE PHENYLEPHRINE | 2007 |
|
RU2450803C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTITHROMBOTIC, THROMBOLYTIC, IMMUNOMODULATORY, ANTI-INFLAMMATORY ACTION, NORMALISING LIPID AND CARBOHYDRATE METABOLISM | 2012 |
|
RU2519741C2 |
| DELAYED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING ASPARAGINATES | 2016 |
|
RU2632713C2 |
| LACTOSE-FREE, NONHYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL PREPARATIONS OF DESCARBOETHOXYLORATADINE | 1998 |
|
RU2209627C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES (VERSIONS) | 2010 |
|
RU2483717C2 |
| NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS | 2000 |
|
RU2238087C2 |
| IMMEDIATE RELEASE COMPOSITIONS | 2010 |
|
RU2541807C2 |
| THREE-PHASE PHARMACEUTICAL FORM WITH CONSTANT AND CONTROLLED RELEASE OF AMORPHOUS ACTIVE INGREDIENT FOR SINGLE DAILY ADMINISTRATION | 1996 |
|
RU2161956C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
